Augmentation is the only major breast procedure that shrank from its peak. Every other category is at all-time highs. The total market is booming — it's just diversifying away from the boob job.
Augmentation is down 12% from its 2007 peak (347,524). Meanwhile: lifts +47%, reconstruction +101%, implant removal at all-time highs, and cosmetic reduction up 76%. The total breast market grew from ~536K in 2007 to 767K in 2024 — a 38% expansion. Augmentation contributed negative volume to that growth.
| Procedure | Peak Year | 2024 | Growth |
|---|---|---|---|
| Augmentation | 347,524 (2007) | 306,196 | −12% from peak |
| Breast lift | 153,616 (2024) | 153,616 | +47% from 2007 |
| Reconstruction | 162,579 (2024) | 162,579 | +101% from 2007 |
| Reduction | 76,734 (2024) | 76,734 | +76% from 2011 |
| Implant removal | 41,271 (2024) | 41,271 | +53% from 2007 |
In 2007, augmentation was nearly two-thirds of all breast surgery. By 2024, it was barely two-fifths. That 24-point share decline happened while the total market grew 38%. If you only look at augmentation, you see a flat market. Look at the total, and it's robust growth.
Every single procedure gained market share at augmentation's expense. Reconstruction doubled. Lifts grew 47%. The total breast surgery market is at all-time highs — augmentation just isn't driving it anymore.
The total breast surgery market is an estimated $4.15 billion in surgeon fees alone — potentially $8+ billion in total patient spending. Augmentation's $1.49B represents only about 36% of total revenue, down from an estimated 55–60% a decade ago. The market diversified into a healthier structure.
Total patient cost (including facility, anesthesia, implants) is typically 1.5–2x surgeon fees, putting the full market at $6–8 billion in total patient spending.
The breast surgery market used to have a clear star. That structure has fundamentally changed. By 2030, augmentation's share may fall to ~37%, with reconstruction potentially challenging it for the #1 spot by volume.